Skip to content

Effect of Cosmix No Nonsense Plant Protein on Muscles gain and weight loss

A double blind Randomized clinical study to study the effect of Cosmix No Nonsense Plant Protein on Muscles gain and weight loss on subjects with Muscle Training - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077249
Enrollment
60
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Cosmix No Nonsense Plant Protein with Enzymes: Test Product: Cosmix No Nonsense Plant Protein, Dose: 1 scope per day 30 minutes post Exercise, Rout of Administration:

Sponsors

Cosmix Wellness Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Male or Female 18 to 50 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4) Are free of any systemic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to join the training program throughout the study duration.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product. 4. Have participated in any interventional clinical trial in the previous 90 days. 5. Have a known sensitivity to any of the constituents of the test product including sensitivities to any ingredient 6. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.

Design outcomes

Primary

MeasureTime frame
Change in Muscle ThicknessTimepoint: Day 0, Day 28

Secondary

MeasureTime frame
Change in Body FatTimepoint: Day 0, Day 28;Change in the weightTimepoint: Day 0, Day 28;Change in the Resting MetabolismTimepoint: Day 0, Day 28

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026